Vascular Pharmaceuticals
Latest round
- Series A
Last raised
- Feb 2015
Total raised
- $25M
Investors
- 3
About Vascular Pharmaceuticals
Vascular Pharmaceuticals, Inc.Founded in 2005 and headquartered in Burlington, US, Vascular Pharmaceuticals, Inc. specializes in treatments for diabetic nephropathy.Vascular Pharmaceuticals focuses on developing innovative treatments for diabetic nephropathy, a serious kidney condition associated with Type 1 and Type 2 diabetes. Their lead product, VPI-2960B, is currently in Phase 2 clinical trials and aims to halt or reverse the progression of this disease, which currently has no cure. The company targets individuals suffering from diabetes, offering a potential breakthrough in treatment options that could improve patient outcomes and enhance quality of life. Vascular Pharmaceuticals plans to market its products primarily in North America and Europe, where the prevalence of diabetes and its complications is significant.Vascular Pharmaceuticals operates on a model that includes partnerships and B2B transactions with healthcare providers and research institutions engaged in diabetes treatment.The company has a strategic focus on advancing VPI-2960B through clinical trials, aiming for market introduction post successful outcomes.
Who invested in Vascular Pharmaceuticals
3 investors across 2 rounds
See all investors in Vascular Pharmaceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Vascular Pharmaceuticals
Who invested in Vascular Pharmaceuticals?
Vascular Pharmaceuticals has 3 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Vascular Pharmaceuticals raised?
Vascular Pharmaceuticals has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Vascular Pharmaceuticals last raise money?
Vascular Pharmaceuticals's most recent round on record is a Series A, in Feb 2015.
What does Vascular Pharmaceuticals do?
Vascular Pharmaceuticals is a pharmaceuticals company.
Where is Vascular Pharmaceuticals headquartered?
Vascular Pharmaceuticals is headquartered in Burlington, US.
Which VCs invest in companies like Vascular Pharmaceuticals?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Vascular Pharmaceuticals's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series A
Raising like Vascular Pharmaceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.